US Stock MarketDetailed Quotes
KTRA Kintara Therapeutics
- 0.1488
- -0.0092-5.82%
Close Apr 26 16:00 ET
- 0.1425
- -0.0063-4.23%
Post 19:59 ET
5.81MMarket Cap-28P/E (TTM)
0.1950High0.1356Low51.61MVolume0.1950Open0.1580Pre Close9.50MTurnover132.25%Turnover RatioLossP/E (Static)39.04MShares5.980052wk High-0.56P/B5.81MFloat Cap0.081052wk Low--Dividend TTM39.03MShs Float6800.0000Historical High--Div YieldTTM37.60%Amplitude0.0810Historical Low0.1840Avg Price1Lot Size
About Kintara Therapeutics Company
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Company Profile
SymbolKTRA
Company NameKintara Therapeutics
Listing DateJul 12, 2016
Founded2009
CEOMr. Robert E. Hoffman, C.P.A.
MarketNASDAQ
Employees17
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address9920 Pacific Heights Boulevard,Suite 150
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-350-4364
Websitehttp://www.kintara.com
Company Executives
- Name
- Position
- Salary
- Robert E. Hoffman, C.P.A.
- Chairman of the Board, Interim Chief Financial Officer, Principal Accounting Officer, President and Chief Executive Officer
- 3.16M
- Laura Johnson
- Independent Director
- 147.49K
- Robert J. Toth, Jr
- Independent Director
- 151.46K
- Tamara A. Favorito
- Independent Director
- 91.34K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg